Literature DB >> 1284374

Prevalence of hepatitis C virus antibody among Korean adults.

Y S Kim1, C H Pai, H S Chi, D W Kim, Y I Min, Y O Ahn.   

Abstract

To estimate the prevalence of hepatitis C virus (HCV) infection among Korean adults and to present the putative route of HCV transmission among them, serum samples from 4917 adults older than 20 years of age were tested for antibody to HCV (anti-HCV), and histories of blood transfusion and other pertinent information were obtained by self-administered questionnaires. The overall prevalence of anti-HCV was 1.7%; prevalence was 1.4% in subjects with normal levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT), 3.3% in those with slightly elevated and 5.9% in those with markedly elevated levels of the enzymes. The prevalence of anti-HCV increased with increasing age (P < 0.01), but was not associated with blood transfusion. The present study suggests that the prevalence of HCV infection was 1.4% and that the major routes of HCV transmission may be other than blood transfusion in healthy Korean adults.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1284374      PMCID: PMC3053841          DOI: 10.3346/jkms.1992.7.4.333

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  12 in total

Review 1.  KASL clinical practice guidelines: management of hepatitis C.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

2.  Cryoglobulinaemia and rheumatic manifestations in patients with hepatitis C virus infection.

Authors:  Y H Lee; J D Ji; J E Yeon; K S Byun; C H Lee; G G Song
Journal:  Ann Rheum Dis       Date:  1998-12       Impact factor: 19.103

3.  The prevalence of hepatitis C virus infection in Korea: pooled analysis.

Authors:  Hai-Rim Shin; Soon Young Hwang; Chung-Mo Nam
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

4.  Vaccination of chimpanzees against infection by the hepatitis C virus.

Authors:  Q L Choo; G Kuo; R Ralston; A Weiner; D Chien; G Van Nest; J Han; K Berger; K Thudium; C Kuo
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

5.  KASL clinical practice guidelines: management of hepatitis C.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2014-06-30

6.  Geographic integration of hepatitis C virus: A global threat.

Authors:  Mohamed A Daw; Abdallah A El-Bouzedi; Mohamed O Ahmed; Aghnyia A Dau; Mohamed M Agnan; Aisha M Drah
Journal:  World J Virol       Date:  2016-11-12

7.  Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case-control study.

Authors:  Jee Hyun Kim; Yung-Jue Bang; Byung Joo Park; Taiwoo Yoo; Chul Woo Kim; Tae-You Kim; Dae Seog Heo; Hyo-Suk Lee; Noe Kyeong Kim
Journal:  Jpn J Cancer Res       Date:  2002-05

8.  Efficacy of peginterferon and ribavirin is associated with the IL28B gene in Korean patients with chronic hepatitis C.

Authors:  Seok Hoo Jeong; Young Kul Jung; Jae Won Yang; Sang Jin Park; Jong Woo Kim; Oh Sang Kwon; Yun Soo Kim; Duck Joo Choi; Ju Hyun Kim
Journal:  Clin Mol Hepatol       Date:  2012-12-21

9.  Body mass index and nonresponse to antiviral treatment in korean patients with genotype 2 and 3 chronic hepatitis C.

Authors:  Yeon Joo Kim; Sung Bum Cho; Sang Woo Park; Hyoung Ju Hong; Du Hyeon Lee; Eun Ae Cho; Hyunsoo Kim; Sung Kyu Choi; Jong Sun Rew
Journal:  Chonnam Med J       Date:  2012-04-26

10.  Hepatitis B and C virus prevalence in a rural area of South Korea: the role of acupuncture.

Authors:  H R Shin; J Y Kim; J I Kim; D H Lee; K Y Yoo; D S Lee; S Franceschi
Journal:  Br J Cancer       Date:  2002-07-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.